Udvalget for Humanmedicinske Lægemidler (CHMP) fandt, at Foscans evne til at lindre symptomerne ved fremskreden kræft i hoved og hals er interessant.
The Committee for Medicinal Products for Human Use (CHMP) concluded that Foscan’ s effects on relieving the symptoms associated with advanced head and neck cancer were of interest.